Sandoz has not minced words about the massive, yet largely untapped opportunity biosimilar makers are presented with as dozens of branded medicines inch toward the patent cliff in the next decade.& | ...

Swiss generic drugmaker Sandoz Group AG has created a global biosimilars unit to capitalize on drugs worth $650 billion ...

Sandoz announced the creation of a new biosimilar development, manufacturing and supply unit that will be headed by industry veteran Armin Metzger, who will join Sandoz on April 1.

Sandoz (SDZNY) stock is in focus as the company launches a new biosimilar unit to target $650B in off-patent biologics. Read ...

The fair value estimate for Sandoz Group has shifted from CHF 58.42 to about CHF 62.57, bringing it closer to Street price targets that now cluster in the CHF 70 to CHF 75 range. This narrower gap ...

Even as Novartis puts its generics outfit under a magnifying glass, Sandoz continues to grow. Angling to beef up in respiratory medicine and complex generics, Sandoz has acquired British medical and ...

(Reuters) -Sandoz shares dipped on their market debut on Wednesday after the generic and biosimilar drugmaker was valued at a lower-than-expected 10.3 billion Swiss francs ($11.2 billion) in its ...

New biosimilar development, manufacturing and supply unit will be headed by Armin Metzger.

TEVA, Sandoz and Dr. Reddy's are shifting toward complex generics and biosimilars to counter pricing pressure and strengthen ...

At an Extraordinary General Meeting, Novartis AG's (NYSE:NVS) shareholders approved the proposed 100% spin-off of Sandoz. Novartis shareholders and Novartis ADR holders will receive one Sandoz share ...

Sandoz is a global leader in the generics and biosimilars sector, with a strong position in the off-patent medicines market. The company recently listed and plans to aggressively pursue a slice of the ...

The company confirmed to the APA news agency that it is planning to close the Development Center, which focuses on the development of generic medicines. The measure would only affect the development ...